Abbonarsi

Total transcriptome, proteome, and allergome of Johnson grass pollen, which is important for allergic rhinitis in subtropical regions - 06/01/15

Doi : 10.1016/j.jaci.2014.06.034 
Bradley C. Campbell, PhD a, ∗, Edward K. Gilding, PhD a, b, ∗, Victoria Timbrell, BBMS c, Preethi Guru, BSc c, Dorothy Loo, MSc d, Danila Zennaro, MD e, Adriano Mari, MD e, f, Graham Solley, MBBS g, Michelle M. Hill, PhD d, Ian D. Godwin, PhD a, Janet M. Davies, PhD c, ⁎
a School of Agriculture and Food Sciences, The University of Queensland, Brisbane, Australia 
b Institute for Molecular Biosciences, The University of Queensland, Brisbane, Australia 
c School of Medicine, Translational Research Institute, The University of Queensland, Brisbane, Australia 
d The University of Queensland Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, Australia 
e Centri Associati di Allergologia Molecolare, Rome, Italy 
f Allergy Data Laboratories s.c., Latina, Italy 
g Watkins Medical Centre, Brisbane, Australia 

∗Corresponding author: Janet M. Davies, PhD, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, QLD 4076 Australia.

Abstract

Background

Genomic data are lacking for many allergen sources. To circumvent this limitation, we implemented a strategy to reveal the repertoire of pollen allergens of a grass with clinical importance in subtropical regions, where an increasing proportion of the world's population resides.

Objective

We sought to identify and immunologically characterize the allergenic components of the Panicoideae Johnson grass pollen (JGP; Sorghum halepense).

Methods

The total pollen transcriptome, proteome, and allergome of JGP were documented. Serum IgE reactivities with pollen and purified allergens were assessed in 64 patients with grass pollen allergy from a subtropical region.

Results

Purified Sor h 1 and Sor h 13 were identified as clinically important allergen components of JGP with serum IgE reactivity in 49 (76%) and 28 (43.8%), respectively, of patients with grass pollen allergy. Within whole JGP, multiple cDNA transcripts and peptide spectra belonging to grass pollen allergen families 1, 2, 4, 7, 11, 12, 13, and 25 were identified. Pollen allergens restricted to subtropical grasses (groups 22-24) were also present within the JGP transcriptome and proteome. Mass spectrometry confirmed the IgE-reactive components of JGP included isoforms of Sor h 1, Sor h 2, Sor h 13, and Sor h 23.

Conclusion

Our integrated molecular approach revealed qualitative differences between the allergenic components of JGP and temperate grass pollens. Knowledge of these newly identified allergens has the potential to improve specific diagnosis and allergen immunotherapy treatment for patients with grass pollen allergy in subtropical regions and reduce the burden of allergic respiratory disease globally.

Il testo completo di questo articolo è disponibile in PDF.

Key words : Allergome, allergen components, allergic rhinitis, IgE, Johnson grass pollen, pollen allergy, proteome, transcriptome

Abbreviations used : AR, 2D, JGP, MS, pI, SPT


Mappa


 Supported by the University of Queensland Collaboration Industry Engagement Fund and a cosponsorship from Stallergenes Pty Ltd. J.M.D. is supported by a National Health and Medical Research Council of Australia Development Grant (1017441). The University of Queensland Diamantina Institute proteomics facility was supported by the National Health and Medical Research Council of Australia Major Equipment and Infrastructure grant and a Ramaciotti Foundations Equipment Gift. M.M.H. is supported by Australian Research Council Future Fellowship (FT120100251).
 Disclosure of potential conflict of interest: E. K. Gilding has received salary and research support from the Australian Research Council (LP0883808) and has received payment for lectures from The University of Queensland. J. M. Davies has received research support from The University of Queensland Collaborative Industry Engagement Fund, the National Health and Medical Research Council, the Asthma Foundation of Queensland, and the Australian Society for Clinical Immunology and Allergy; has consultant arrangements with Stallergenes Australia; is employed by The University of Queensland; has received payment from Stallergenes Pty Ltd and GlaxoSmithKline for lectures delivered by J. M. Davies; the university has received travel support from Thermo Fisher; is the named inventor on patent granted in Australia and applied for in the United States for Novel immunogenic molecules and uses thereof: Immunogenic protein Pas n 1 from Bahia grass pollen; receives in-kind support for development of her research from Thermo Fisher by way of provision of materials; and receives in-kind support for development of her research from Sullivan Nicolaides Pathology by way of provision of pathology services. The rest of the authors declare that they have no relevant conflicts of interest.


© 2014  American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 135 - N° 1

P. 133-142 - gennaio 2015 Ritorno al numero
Articolo precedente Articolo precedente
  • Perception versus reality: The saga of inhaled asthma controller medication and fetal risk
  • Joshua A. Steinberg
| Articolo seguente Articolo seguente
  • Identifying the heterogeneity of young adult rhinitis through cluster analysis in the Isle of Wight birth cohort
  • Ramesh J. Kurukulaaratchy, Hongmei Zhang, Veeresh Patil, Abid Raza, Wilfried Karmaus, Susan Ewart, S. Hasan Arshad

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.